Theranos Finally Bleeds Out

Theranos Finally Bleeds Out

Blood-testing company Theranos, once worth $9 billion, is dissolving, having hemorrhaged billions thanks to fraudulent claims—not to mention actual fraud committed—by founder and "industry disruptor" Elizabeth Holmes.


POC IVD a Viable Business Model for Theranos

POC IVD a Viable Business Model for Theranos

Intrigue regarding stealthy diagnostics and lab testing company Theranos has given way to controversy as recent reports and allegations question the efficacy of the company’s core technology. Theranos recently disclosed that the fingerstick sampling method used in conjunction with its in-house developed IVD analyzer, referred to as ‘Edison’ in reports, is now limited to only one test, a FDA-approved laboratory developed test (LDT) for herpes simplex virus-1 (HSV-1). The reduced role of Theranos’...